Analyst Reco. MegaPro Biomedical Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-28 EDT			5-day change	1st Jan Change
22.55 ^TWD	-1.53%		-3.63%	-7.39%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

No results for this search